
浏览全部资源
扫码关注微信
1.安徽省胸科医院内三科,合肥 230022
2.合肥医工医药股份有限公司,合肥 230601
副主任医师。研究方向:呼吸康复、呼吸系统临床药物应用。E-mail:pengwenjuan1983@sina.com
主任药师,博士。研究方向:创新药物研发、分子药理学。E-mail:chuzhaoxing@163.com
收稿日期:2025-03-28,
修回日期:2025-04-27,
录用日期:2025-07-10,
纸质出版日期:2025-08-15
移动端阅览
彭文娟,赵炎,岳少云,等.枸地氯雷他定对小鼠过敏性肺炎的改善作用及机制[J].中国药房,2025,36(15):1882-1886.
PENG Wenjuan,ZHAO Yan,YUE Shaoyun,et al.Improvement effect and mechanism of desloratadine citrate disodium in hypersensitivity pneumonitis model mice[J].ZHONGGUO YAOFANG,2025,36(15):1882-1886.
彭文娟,赵炎,岳少云,等.枸地氯雷他定对小鼠过敏性肺炎的改善作用及机制[J].中国药房,2025,36(15):1882-1886. DOI: 10.6039/j.issn.1001-0408.2025.15.11.
PENG Wenjuan,ZHAO Yan,YUE Shaoyun,et al.Improvement effect and mechanism of desloratadine citrate disodium in hypersensitivity pneumonitis model mice[J].ZHONGGUO YAOFANG,2025,36(15):1882-1886. DOI: 10.6039/j.issn.1001-0408.2025.15.11.
目的
2
探讨枸地氯雷他定对小鼠过敏性肺炎(HP)的改善作用及机制。
方法
2
将60只小鼠按随机数字表法分为空白对照组(生理盐水)、模型组(生理盐水)、泼尼松组(阳性对照,20 mg/kg)和枸地氯雷他定低、中、高剂量组(0.5、1、2 mg/kg),每组10只。除空白对照组外,其余各组小鼠均通过腹腔注射卵清蛋白和吸入卵清蛋白喷雾构建HP模型。从造模第22天开始,各组小鼠灌胃相应药物/生理盐水,每天1次,连续11 d。末次给药后,评估各组小鼠肺功能和气道高反应性,检测血清中白细胞介素(IL)-1β、IL-4、IL-6水平和支气管肺泡灌洗液中IL-8、IL-13、IL-17A水平,观察各组小鼠肺组织Masson染色病理变化,检测肺组织中纤维化相关蛋白转化生长因子β
1
(TGF-β
1
)、3型胶
原蛋白(Col-Ⅲ)和纤维连接蛋白(FN)的表达。
结果
2
与空白对照组比较,模型组小鼠肺功能显著降低(
P
<0.01),气道阻力和血清中IL-1β、IL-4、IL-6水平以及支气管肺泡灌洗液中IL-8、IL-13、IL-17A水平均显著升高(
P
<0.01);肺组织出现肺泡塌陷、萎缩及结构紊乱,并生成大量蓝色胶原纤维沉积,阳性染色百分比显著升高(
P
<0.01);肺组织中TGF-β
1
、Col-Ⅲ和FN蛋白表达水平均显著升高(
P
<0.01)。给予枸地氯雷他定干预后,枸地氯雷他定各剂量组小鼠肺组织病理变化均有不同程度改善,以上指标水平大部分显著逆转(
P
<0.05或
P
<0.01)。
结论
2
枸地氯雷他定可改善HP小鼠的肺功能和气道高反应性,抑制血清和支气管肺泡灌洗液中炎症因子的释放,降低胶原纤维的沉积,其作用机制可能与抗炎、调节免疫和抗纤维化相关。
OBJECTIVE
2
To investigate the improvement effect and mechanism of desloratadine citrate disodium in mice with hypersensitivity pneumonitis (HP).
METHODS
2
Sixty mice were randomly divided into blank control group (normal saline), model group (normal saline), prednisone group (positive control, 20 mg/kg) and desloratadine citrate disodium low-, medium- and high-dose groups (0.5, 1, 2 mg/kg), with 10 mice in each group. Except for the blank control group, mice in other groups were intraperitoneally injected with ovalbumin (OVA) and exposed to OVA inhalation to establish the HP model. On day 22 post-modeling, mice in each group were administered the corresponding drugs or normal saline, once a day, for 11 consecutive days. After the last administration, lung function and airway hyperreactivity were assessed. The levels of interleukin-1β (IL-1β), IL-4 and IL-6 in serum as well as the levels of IL-8, IL-13 and IL-17A in bronchoalveolar lavage fluid were determined. Pathological changes in lung tissue of mice were evaluated using Masson staining. Furthermore, the expressions of fibrosis-related proteins, including transforming growth factor β
1
(TGF-β
1
), type Ⅲ collagen (Col-Ⅲ) and fibronectin (FN) were determined in lung tissues.
RESULTS
2
Compared with the blank control group, the model group showed signif
icant deterioration in lung function (
P
<0.01), while airway resistance and serum levels of IL-1β, IL-4, IL-6 and the levels of IL-8, IL-13 and IL-17A in the bronchoalveolar lavage fluid were increased significantly (
P
<0.01). The lung tissues exhibited alveolar collapse, atrophy, and structural disarray, along with the formation of extensive deposits of blue collagen fibers, the percentage of positive staining increased significantly (
P
<0.01). Additionally, the expression levels of TGF-β
1
, Col-Ⅲ, and FN proteins in the lung tissues were also increased significantly (
P
<0.01). After intervention with desloratadine citrate disodium, the pathological changes in the lung tissues of mice in each dosage group of desloratadine citrate disodium showed varying degrees of improvement, and most of the aforementioned indicator levels were significantly reversed (
P
<0.05 or
P
<0.01).
CONCLUSIONS
2
Desloratadine citrate disodium can improve the lung function and airway hyperreactivity of HP mice, inhibit the release of inflammatory factors in serum and bronchoalveolar lavage fluid, and reduce the deposition of collagen fibers. Its mechanism of action may be related to anti-inflammatory, immunomodulatory, and antifibrotic effects.
胡芸倩 , 欧鑫鋆 , 朱晓萍 . 过敏性肺炎的诊断和治疗进展 [J ] . 上海医药 , 2021 , 42 ( 10 ): 3 - 6 .
RAGHU G , REMY-JARDIN M , RYERSON C J , et al . Diagnosis of hypersensitivity pneumonitis in adults. An official ATS/JRS/ALAT clinical practice guideline [J ] . Am J Respir Crit Care Med , 2020 , 202 ( 3 ): e36 - e69 .
SPAGNOLO P , ROSSI G , CAVAZZA A , et al . Hypersensitivity pneumonitis:a comprehensive review [J ] . J Invest Allerg Clin , 2015 , 25 ( 4 ): 237 - 250 .
MORISSET J , JOHANNSON K A , VITTINGHOFF E , et al . Use of mycophenolate mofetil or azathioprine for the management of chronic hypersensitivity pneumonitis [J ] . Chest , 2017 , 151 ( 3 ): 619 - 625 .
王焕玲 , 程伟 , 韦艳芹 , 等 . 枸地氯雷他定对慢性荨麻疹的治疗效果及安全性评价 [J ] . 系统医学 , 2024 , 9 ( 1 ): 149 - 152 .
CHEN M L , XU S H , ZHOU P P , et al . Desloratadine citrate disodium injection,a potent histamine H(1) receptor antagonist,inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-κB signal cascades [J ] . Eur J Pharmacol , 2015 , 767 : 98 - 107 .
ZHANG Y Y , LI W . Effects of oral desloratadine citrate disodium combined with physiological seawater nasal irrigation on IgE levels,IL-4,IL-6,IL-13 and IFN-γ expression and treatment of intermittent allergic rhinitis [J ] . Cell Mol Biol (Noisy-le-grand) , 2020 , 66 ( 5 ): 54 - 58 .
LEE S J , LEE A Y , PAK S W , et al . Protective effects of Angelica decursiva Franchet & Savatier on allergic responses through enhancement of Nrf2 and suppression of NF-κB/MMP-9 in ovalbumin-exposed mice [J ] . J Ethnopharmacol , 2024 , 318 ( Pt A ): 116863 .
PAK S W , LEE I S , KIM W I , et al . Melia azedarach L. reduces pulmonary inflammation and mucus hypersecretion on a murine model of ovalbumin exposed asthma [J ] . J Ethnopharmacol , 2024 , 320 : 117426 .
WOLFF C H J . Innate immunity and the pathogenicity of inhaled microbial particles [J ] . Int J Biol Sci , 2011 , 7 ( 3 ): 261 - 268 .
LIU H , JAKUBZICK C , OSTERBURG A R , et al . Dendritic cell trafficking and function in rare lung diseases [J ] . Am J Respir Cell Mol Biol , 2017 , 57 ( 4 ): 393 - 402 .
MORSI A A , FARUK E M , MOGAHED M M , et al . Mode- ling the effects of cypermethrin toxicity on ovalbumin-induced allergic pneumonitis rats:macrophage phenotype differentiation and p38/STAT6 signaling are candidate targets of pirfenidone treatment [J ] . Cells , 2023 , 12 ( 7 ): 994 .
VASAKOVA M , SELMAN M , MORELL F , et al . Hypersensitivity pneumonitis:current concepts of pathogenesis and potential targets for treatment [J ] . Am J Respir Crit Care Med , 2019 , 200 ( 3 ): 301 - 308 .
ELMORE J , CARTER C , REDKO A , et al . ITK independent development of Th17 responses during hypersensitivity pneumonitis driven lung inflammation [J ] . Commun Biol , 2022 , 5 ( 1 ): 162 .
0
浏览量
15
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
公网安备50010302001817